Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research and Development Contracts (N01)
Project #: N01AI030053-009
Application #: 7329529
Study Section

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year: 2006
Total Cost
Indirect Cost

Institution

Name: Vaxgen Inc.
Department
Type
DUNS #

City
State
Country
Zip Code

Related projects


NIH 2006 N01 AI	Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053 / Vaxgen Inc.
NIH 2005 N01 AI	Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053 / Vaxgen Inc.
NIH 2004 N01 AI	Production and Testing of rPA Vaccine-26630053 / Vaxgen Inc.
NIH 2003 N01 AI	Production and Testing of Anthrax Recombinant Protective Antigen Vacci- / Vaxgen Inc.

Publications

Omland, Kristian S; Brys, April; Lansky, David et al. (2008) Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species. Clin Vaccine Immunol 15:946-53

Comments

Be the first to comment on this grant